Halofuginone | CAS#64924-67-0貨號B2610-10

| 代理廠牌: | ![]() |
| 原廠連結: | |
| 相關下載: |
特點
Home Literature Promotions Product Citations

產品描述: Halofuginone是一種ATP依賴性抑制劑脯氨酰tRNA合成酶(Ki為18.3 nM)。 Halofuginone通過抑制TGF-β活性來減輕骨關節炎(osteoarthritis , OA)。阻斷MMP2的表達並抑制ECM在小鼠膀胱癌細胞的體外和肺轉移(lung metastasis)。通過激活氨基酸反應(amino acid response , AAR)途徑,還抑制了多發性硬化小鼠模型中Th17驅動的自身免疫的發展。
穀胱甘肽過氧化物酶活性測定 | FRAP檢測 | 總膠原蛋白分析 | Dopamine多巴胺檢測 | 三酸甘油酯分析 | Cholesterol Efflux膽固醇排出螢光分析 | 脂質過氧化(MDA)測定 | 支鏈氨基酸 BCAA檢測
| Alternate Name | RU-19110, (2R*,3S*)-7-Bromo-6-chloro-3-[3-(3-hydroxy-2-piperidinyl)-2-oxopropyl]-4-3H-quinazolinone hydrobromide |
| Peptide Sequence | N/A |
| Appearance | White solid |
| CAS # | 64924-67-0 |
| Molecular Formula | C₁₆H₁₇BrClN₃O₃.HBr |
| Molecular Weight | 495.59 |
| Purity | ≥98% |
| Solubility | >45 mg/ml in DMSO |
| SMILES | C1CC(C(NC1)CC(=O)CN2C=NC3=CC(=C(C=C3C2=O)Cl)Br)O.Br |
| InChi | InChI=1S/C16H17BrClN3O3.BrH/c17-11-6-13-10(5-12(11)18)16(24)21(8-20-13)7-9(22)4-14-15(23)2-1-3-19-14;/h5-6,8,14-15,19,23H,1-4,7H2;1H/t14-,15+;/m0./s1 |
| InChi Key | SJUWEPZBTXEUMU-LDXVYITESA-N |
| PubChem CID | 400771 |
| Handling | Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure. |
| Storage Conditions | -20ºC |
| Shipping Conditions | Gel Pack |
| USAGE | For Research Use Only! Not For Use in Humans. |
乾浴加熱水浴槽 | Finnpipette F3 微量分注器 | 試管振盪器 Vortex Mixer | Genereach迷你型微量離心機 | ELISA儀器
